Topic: clinical research collaboration
Abbott pledged to provide its neuromodulation tech for the public-private NIH research effort.
PerkinElmer signed on to Accenture’s life science ecosystem to integrate its tech into the cloud-based platform’s drug discovery efforts.
Concerto HealthAI has inked its second real-world data collaboration with a Big Pharma company in as many weeks.
The BRACAnalysis CDx test will be used to hunt for germline BRCA mutations in men eligible for the Big Pharmas’ PARP-inhibiting Lynparza therapy.
AstraZeneca has signed on to be a founding partner for a new life sciences research hub in China, to be housed just west of Shanghai.
C4 Therapeutics has poached a new CMO to help carry its targeted protein degraders closer to the clinic through collabs with Biogen, Calico and Roche.
Purdue Pharma’s new R&D subsidiary, Imbrium Therapeutics, tapped TetraGenetics and its antibody discovery platform for non-opioid-based painkillers.
Celgene signed on for about $1 billion for a Canadian preclinical asset: a small molecule targeting protein-protein interactions in blood cancers.
Basilea Pharmaceutica will collaborate with its fellow Basel-based biotech, Roche, to test a combination immunotherapy in advanced urothelial cancer.
Gamida Cell brought on a subsidiary of the National Marrow Donor Program to support a phase 3 study of its blood cancer cell therapy alternative.